全球疼痛管理设备市场规模、份额、成长分析、按产品（电刺激器、射频消融 (RFA)）、按应用（癌症、神经性疼痛）- 2024-2031 年产业预测

Global Pain Management Devices Market Size, Share, Growth Analysis, By Product(Electrical Stimulators, Radiofrequency Ablation (RFA)), By Application(Cancer, Neuropathic Pain) - Industry Forecast 2024-2031

出版日期: 2024年04月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球疼痛管理设备市场规模约为70亿美元，预计将从2023年的76.5亿美元增至2031年的155.8亿美元，预测期内（2024-2031年）复合年增长率为9.3% ）。

慢性病盛行率的不断上升是预计在整个预测期内推动市场成长的关键驱动因素。由于糖尿病和肥胖等与生活方式相关的疾病的发生率不断上升，肌肉和神经刺激器的需求不断增加。此外，创伤或高血压盛行率的上升被认为是可能有助于市场扩张的另一个重要因素。值得注意的是，高血压会显着增加脑动脉瘤和其他慢性疾病等疾病的风险。 COVID-19 大流行的广泛影响几乎为所有行业带来了经济后果，包括医疗器材产业。全州范围内的封锁措施打乱了严重依赖物理治疗或运动来控制疼痛的患者的日常生活。此外，许多择期手术和麵对面的患者咨询被推迟或取消，预计这将增加对家庭疼痛管理解决方案的需求。为了满足这一需求，欧姆龙于 2020 年 4 月扩大了其无药疼痛管理设备的范围，推出了用于膝盖疼痛的新型 Focus TENS 治疗设备。此外，预测期内癌症病例的预期增加预计将进一步刺激需求。此外，关节炎、骨关节炎、骨科退化性疾病和类风湿性关节炎等肌肉骨骼疾病的盛行率正在上升。这导致受影响个体的慢性疼痛激增和日常活动受限。例如，疾病预防控制中心估计，到 2020 年，关节炎将影响超过 24.5% 的美国成年人，使其成为与工作相关的残疾的主要原因。慢性疼痛盛行率的增加因此刺激了对疼痛管理刺激器的需求。此外，预计到 2020 年将有约 3,250 万美国人患有骨关节炎。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Abbott Laboratories
Medtronic
Boston Scientific
Pfizer
Johnson & Johnson
Nevro Corporation
Baxter International
St. Jude Medical
B. Braun Melsungen AG
Smiths Medical
Hospira
Endo International
Djo Global
Halyard Health
Stryker Corporation
NeuroMetrix
Avanos Medical
NIPRO Corporation
Terumo Corporation
Stimwave Technologies

简介目录

Product Code: SQMIG35A2502

Global pain management devices market size was valued at around 7.0 billion in 2022 and is expected to rise from USD 7.65 billion in 2023 to reach a value of USD 15.58 billion by 2031, at a CAGR of 9.3% over the forecast period (2024-2031).

The increasing prevalence of chronic diseases stands out as a key driver expected to propel market growth throughout the forecast period. Muscle and nerve stimulators are experiencing heightened demand due to the escalating occurrence of lifestyle-related conditions such as diabetes and obesity. Additionally, the rising prevalence of trauma or hypertension is identified as another significant factor likely to contribute to market expansion. It's worth noting that hypertension significantly amplifies the risk of conditions like brain aneurysm and other chronic illnesses. The widespread impact of the COVID-19 pandemic has brought economic consequences to nearly every industry, including the medical device sector. Statewide lockdown measures have disrupted the routines of patients heavily reliant on physical therapy or exercise for pain management. Moreover, many elective surgeries and in-person patient consultations have been delayed or canceled, which is expected to drive up the demand for at-home pain management solutions. Omron responded to this demand by expanding its range of drug-free pain management devices in April 2020 with the introduction of the new Focus TENS Therapy device for knee pain. Additionally, the projected increase in cancer cases over the forecast period is anticipated to further boost demand. Furthermore, the prevalence of musculoskeletal conditions such as arthritis, osteoarthritis, orthopedic degenerative diseases, and rheumatoid arthritis is on the rise. This has led to a surge in chronic pain and limitations in daily activities among affected individuals. For instance, the CDC estimates that arthritis affected over 24.5% of American adults in 2020, making it the leading cause of work-related disability. This increased prevalence of chronic pain has consequently fueled demand for pain management stimulators. Moreover, approximately 32.5 million Americans were expected to have osteoarthritis in 2020. Furthermore, it is anticipated that technological advancements will further drive market growth, significantly expanding companies' portfolios.

Top-down and bottom-up approaches were used to estimate and validate the size of the global pain management devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pain Management Devices Market Segmental Analysis

The global pain management devices market is segmented based on product, application, and region. By product, the market is segmented into electrical stimulators, radiofrequency ablation (RFA), analgesic infusion pumps, and neurostimulation. By application, the market is segmented into cancer, neuropathic pain, facial & migraine, musculoskeletal disorder, trauma, and others. By region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Pain Management Devices Market

The increasing prevalence of chronic pain conditions, including arthritis, cancer, and back pain, plays a significant role in driving the pain management device market. With a growing global population affected by various chronic pain ailments like arthritis, lower back pain, and neuropathic pain, there is a rising demand for advanced pain management solutions. These devices offer non-invasive or minimally invasive alternatives to traditional pain management methods, ultimately improving patients' comfort and quality of life. Consequently, the pain management device market is experiencing substantial growth, fueled by both healthcare professionals and patients seeking innovative and effective solutions to alleviate chronic pain while reducing their reliance on pharmaceutical treatments.

Restraints in the Global Pain Management Devices Market

The considerable expense associated with pain management devices serves as a notable impediment to market expansion. Many of these devices come with a hefty price tag, rendering them financially out of reach for certain patients and healthcare systems. This high cost presents a significant hurdle within the pain management device market, limiting access for numerous patients and healthcare facilities. As a result, their ability to acquire and utilize these advanced pain management technologies is curtailed. Consequently, the market may encounter slower adoption rates and restricted growth potential as potential customers explore more affordable options or encounter difficulties in securing the necessary funding for these devices. This scenario affects the overall dynamics of the market and poses challenges for manufacturers and providers, impacting their opportunities for growth and innovation.

Market Trends of the Global Pain Management Devices Market

There is a growing trend among patients towards seeking non-invasive pain management solutions, particularly through the use of transcutaneous electrical nerve stimulation (TENS) devices and wearable pain management devices. These options are gaining traction for their accessibility and convenience, as they offer targeted pain relief without the requirement for surgery or medication. As a result, these types of devices are becoming increasingly accessible and popular among individuals seeking effective pain management methods.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Pain Management Devices Market by Product

Market Overview
Electrical Stimulators
Radiofrequency Ablation (RFA)
Analgesic Infusion Pumps
and Neurostimulation

Global Pain Management Devices Market by Application

Market Overview
Cancer
Neuropathic Pain
Facial & Migraine
Musculoskeletal Disorder
Trauma
and Others

Global Pain Management Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
St. Jude Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hospira
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Djo Global
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Halyard Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroMetrix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanos Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NIPRO Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stimwave Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments